An Alabama couple recently filed a lawsuit over Invokana risks against Janssen Pharmaceuticals, alleging the drug caused diabetic ketoacidosis.

Plaintiff Christie P. alleges in this lawsuit that Invokana risks are greater than the manufacturer warned.

The Invokana lawsuit claims that manufacturer Janssen Pharmaceuticals, a subsidiary of pharmaceutical giant Johnson & Johnson, either knew or should have known about the serious risks associated with the use of their drug.

However, the lawsuit claims, Janssen continued to market the drug as safe and effective, defending it against allegations of risk.

The lawsuit further claims that the company actively misled consumers and the medical community by concealing and minimizing information about Invokana risks.

This lawsuit over Invokana risks was filed on multiple counts, including defective design, failure to warn, negligence, breach of express and implied warranties, fraudulent misrepresentation and concealment, and loss of consortium, among others.

Invokana Background

Invokana (also known as cangliflozin) was first introduced to the drug market in 2013.

Invokana is one of several diabetes drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, a relatively new class of diabetes drugs.

After its release onto the diabetes drug market, Invokana quickly rose in popularity, after aggressive marketing tactics by Janssen Pharmaceuticals.

Invokana Risks: Ketoacidosis

However, since its release, the FDA has received a growing number of adverse event reports regarding the drug, and has required Janssen to add a series of warnings to the Invokana warning label.

The warning urged users to be aware of diabetic ketoacidosis symptoms like abdominal pain, fatigue, nausea, respiratory problems, and vomiting.

According to a recent study published in the medical journal Diabetes Care, Invokana can slightly increase the risk of ketoacidosis. Diabetic ketoacidosis is a condition caused by high acid levels in the blood.

Diabetic ketoacidosis can result in some serious symptoms, including:

• Difficulty breathing
• Nausea and vomiting
• Abdominal pain
• Confusion
• Fatigue
• Sleepiness

These diabetic ketoacidosis symptoms can require urgent medical treatment, and can even result in major health problems.

Though the increased risk is fairly low, the condition can result in severe health complications, even involving emergency hospital treatment.

Filing an Invokana Lawsuit

A growing number of injured consumers, amid the FDA warnings and recent studies, are pursuing Invokana lawsuits.

These plaintiffs allege that the drug maker failed to adequately warn about potential Invokana risks, including diabetic ketoacidosis.

These Invokana diabetic ketoacidosis lawsuits claim that the drug makers actively withheld information about Invokana risks from both the medical community and the general public. Some of these Invokana lawsuits claim that the potential Invokana risks, including diabetic ketoacidosis, may outweigh its benefits.

If you or someone you love has suffered due to Invokana risks, including diabetic ketoacidosis, from Invokana, you may be able to file a lawsuit.

While filing a lawsuit cannot reverse the side effects of Invokana, pursuing an Invokana lawsuit could result in financial compensation that would help with medical expenses and lost wages.

The Invokana Risks Lawsuit is Case No. 3:16-cv-07572, in the U.S. District Court for the District of New Jersey, Trenton Division.